Enhanced wound regeneration by PGS/PLA fiber dressing containing platelet-rich plasma: an in vitro study

Parisa Heydari,Anousheh Zargar Kharazi,Laleh Shariati
DOI: https://doi.org/10.1038/s41598-024-62855-w
IF: 4.6
2024-05-27
Scientific Reports
Abstract:Novel wound dressings with therapeutic effects are being continually designed to improve the wound healing process. In this study, the structural, chemical, physical, and biological properties of an electrospun poly glycerol sebacate/poly lactide acid/platelet-rich plasma (PGS/PLA-PRP) nanofibers were evaluated to determine its impacts on in vitro wound healing. Results revealed desirable cell viability in the Fibroblast (L929) and macrophage (RAW-264.7) cell lines as well as human umbilical vein endothelial cells (HUVEC). Cell migration was evident in the scratch assay (L929 cell line) so that it promoted scratch contraction to accelerate in vitro wound healing. Moreover, addition of PRP to the fiber structure led to enhanced collagen deposition (~ 2 times) in comparison with PGS/PLA scaffolds. While by addition PRP to PGS/PLA fibers not only decreased the expression levels of pro-inflammatory cytokines (IL-6 and TNF-α) in RAW-264.7 cells but also led to significantly increased levels of cytokine (IL-10) and the growth factor (TGF-β), which are related to the anti-inflammatory phase (M2 phenotype). Finally, PGS/PLA-PRP was found to induce a significant level of angiogenesis by forming branching points, loops, and tubes. Based on the results obtained, the PGS/PLA-PRP dressing developed might be a promising evolution in skin tissue engineering ensuring improved wound healing and tissue regeneration.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper aims to address issues in the skin wound healing process, particularly the challenges in chronic wound treatment. The research focuses on developing a novel wound dressing by combining poly(glycerol sebacate)/polylactic acid (PGS/PLA) nanofibers with platelet-rich plasma (PRP) to promote in vitro wound healing. Specifically, the study attempts to: 1. **Improve cell viability**: Evaluate the impact of PGS/PLA-PRP nanofibers on the cell viability of fibroblasts (L929), macrophages (RAW-264.7), and human umbilical vein endothelial cells (HUVEC). 2. **Promote cell migration**: Observe cell migration through scratch assays (L929 cell line) to verify its promotion of in vitro wound healing. 3. **Enhance collagen deposition**: Compare the differences in collagen deposition between PGS/PLA-PRP and pure PGS/PLA scaffolds. 4. **Regulate inflammatory response**: Investigate whether the addition of PRP can reduce the expression levels of pro-inflammatory cytokines (such as IL-6 and TNF-α) and increase the expression of anti-inflammatory cytokines (such as IL-10) and growth factors (such as TGF-β), thereby promoting the transition of macrophages to an anti-inflammatory phenotype (M2 phenotype). 5. **Promote angiogenesis**: Assess the ability of PGS/PLA-PRP scaffolds to induce angiogenesis, including the formation of branching points, loops, and tubular structures. In summary, through various experiments, this paper aims to verify the potential of PGS/PLA-PRP nanofibers as a novel wound dressing in accelerating and improving the wound healing process.